Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

Clinical trial NCT03523572 · COMPLETED

Trial details

NCT number: NCT03523572
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Urothelial Carcinoma

Start date: 2018-08-02
Primary completion: 2021-07-22
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.